Trading & Distribution · Wholesale Distributors · NSE: SAROJA · data 2026-10-30
Saroja Pharma Industries India Ltd.
In plain words
Price: 10.4% below its 52-week high of ₹43.3.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹71 cr |
| Net profit (last 12 months) | ₹2 cr |
| Sales growth, 3 years (yearly) | 11.8% |
| Profit growth, 3 years (yearly) | 15.0% |
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Saroja Pharma Industries India Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.83.
What is Saroja Pharma Industries India Ltd.'s P/E ratio?
About 9.7, based on the last 12 months' earnings and a price of ₹38.8 (data 2026-10-30).
What is the 52-week high and low of Saroja Pharma Industries India Ltd.?
The 52-week high is ₹43.3 and the 52-week low is ₹28.
Similar companies
QVC Exports Limited (QVCEL) · Aspire & Innovative Advertising Limited (ASPIRE) · Sri Havisha Hospitality And Infrastructure Ltd (HAVISHA) · Agarwal Float Glass India Limited (AGARWALFT) · Shrenik Limited (SHRENIK)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SAROJA in NSE Scanner →